Fig. 7

MiR-210-3p decreased the drug resistance of RCC. DOX was used to inject into the mice injected by Caki-2 cells with miR-210-3p inhibition. a The tumor volume was markly enhanced in the mice of miR-210-3p inhibitor group. b The levels of ABCC1 and MDR-1 were also enhanced in the mice of miR-210-3p inhibitor group. *P < 0.05 vs. NC